Ligand · BD8
BD8 · N-undecanoyl-L-histidyl-L-phenylalanyl-N-methyl-N-(2-pyridin-2-ylethyl)-L-tyrosinamide
BD8, N-undecanoyl-L-histidyl-L-phenylalanyl-N-methyl-N-(2-pyridin-2-ylethyl)-L-tyrosinamide (C43 H57 N7 O5, 752.0 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within…
- Component
- BD8
- Formula
- C43 H57 N7 O5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
BD8 in 2 structures; the first of them:
- 3HXE · Engineered RabGGTase in complex with a peptidomimetic inhibitor (compound 37) · BD8 B334 · binds TYR107, TYR30, SER42, LEU45, ARG46, SER48, GLY49, TYR51 and 24 more
- 3HXE · Engineered rabggtase in complex with a peptidomimetic inhibitor (compound 37) · BD8 B334 · binds TYR107, TYR30, SER42, LEU45, ARG46, SER48, GLY49, TYR51 and 24 more
Residues it binds most
TYR 2, CYS 2, PHE 2, LEU 2, TRP 2, ARG 2, ASP 2, GLN 2, GLY 2, HIS 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.